408
Chapter 11
299. BagnallMJ, Evans AJ,WilsonAR, et al. Predicting invasion inmammo-
graphically detected microcalcification.
Clin Radiol
2001;56:828–832.
300. Hoorntje LE, Schipper ME, Peeters PH, et al. The finding of inva-
sive cancer after a preoperative diagnosis of ductal carcinoma
in situ
:
causes of ductal carcinoma
in situ
underestimates with stereotactic
14-gauge needle biopsy.
Ann Surg Oncol
2003;10:748–753.
301. Yen TW, Hunt KK, Ross MI, et al. Predictors of invasive breast cancer
in patients with an initial diagnosis of ductal carcinoma
in situ
: a guide
to selective use of sentinel lymph node biopsy in management of duc-
tal carcinoma
in situ
.
J Am Coll Surg
2005;200:516–526.
302. Cowen PN. Recognition of intraduct mammary carcinoma.
J Clin
Pathol
1980;33:797.
303. Cowen PN, Bates C. The significance of intraduct appearances in
breast cancer.
Clin Oncol
1984;10:67–72.
304. Barsky SH, Doberneck SA, Sternlicht MD, et al. ‘Revertant’ DCIS in hu-
man axillary breast carcinoma metastases.
J Pathol
1997;183:188–194.
305. Arihiro K, Inai K, Kurihara K, et al. Distribution of laminin, type IV
collagen and fibronectin in the invasive component of breast carci-
noma.
Acta Pathol Japonica
1993;43:758–764.
306. Nadji M, Nassiri M, Fresno M, et al. Laminin receptor in lymph node
negative breast carcinoma.
Cancer
1999;85:432–436.
307. Solin LJ, Fowble BL, Yeh I-T,et al. Microinvasive ductal carcinoma
of the breast treated with breast-conserving surgery and definitive ir-
radiation.
Int J Radiat Oncol Biol Phys
1992;23:961–968.
308. Silver SA, Tavassoli FA. Mammary ductal carcinoma
in situ
with mi-
croinvasion.
Cancer
1998;82:2382–2390.
309. de Mascarel I, MacGrogan G, Mathoulin-Pelissier S, et al. Breast duc-
tal carcinoma
in situ
with microinvasion. A definition supported by a
long-term study of 1248 serially sectioned ductal carcinomas.
Cancer
2002;94:2134–2142.
310. Jimenez RE, Visscher DW. Clinicopathologic analysis of microscopi-
cally invasive breast carcinoma.
Hum Pathol
1998;29:1412–1419.
311. Walker RA, Dearing SJ, Brown LA. Comparison of pathological and
biological features of symptomatic and mammographically detected
ductal carcinoma
in situ
of the breast.
Hum Pathol
1999;30:943–948.
312. Prasad ML, Osborne MP, Giri DD, et al. Microinvasive carcinoma
(T1
mic
) of the breast. Clinicopathologic profile of 21 cases.
Am J Surg
Pathol
2000;24:422–428.
313. Ross DS, Hoda SA. Microinvasive (T1
mic
) lobular carcinoma of
the breast: clinicopathologic profile of 16 cases.
Am J Surg Pathol
2011;35:750–756.
314. Shapiro-Wright HM, Julian TB. Sentinel lymph node biopsy and man-
agement of the axilla in ductal carcinoma
in situ
.
J Natl Cancer Inst
Monogr
2010;2010(41):145–149.
315. Moore KH, Sweeney KJ, Wilson ME, et al. Outcomes for women with
ductal carcinoma-
in-situ
and a positive sentinel node: a multi-institu-
tional audit.
Ann Surg Oncol
2007;14:2911–2917.
316. Intra M, Rotmensz N, Veronesi P, et al. Sentinel node biopsy is not a
standard procedure in ductal carcinoma
in situ
of the breast: the ex-
perience of the European Institute of Oncology on 854 patients in 10
years.
Ann Surg
2008;247:315–319.
317. Zavotsky J, Hansen N, Brennan MB, et al. Lymph node metas-
tasis from ductal carcinoma
in situ
with microinvasion.
Cancer
1999;85:2439–2443.
318. Dauway EL, Giuliano R, Pendas S, et al. Lymphatic mapping: a tech-
nique providing accurate staging for breast cancer.
Breast Cancer
1999;6:145–154.
319. Wilkie C, White L, Dupont E, et al. An update of sentinel lymph
node mapping in patients with ductal carcinoma
in situ
.
Am J Surg
2005;190:563–566.
320. Katz A, Gage I, Evans S, et al. Sentinel lymph node positivity of pa-
tients with ductal carcinoma
in situ
or microinvasive breast cancer.
Am J Surg
2006;191:761–766.
321. Sakr R, Barranger E, Antoine M, et al. Ductal carcinoma
in situ
: value
of sentinel lymph node biopsy.
J Surg Oncol
2006;94:426–430.
322. Leidenius M, Salmenkivi K, von Smitten K, et al. Tumour-positive
sentinel node findings in patients with ductal carcinoma
in situ
.
J Surg
Oncol
2006;94:380–384.
323. Huo l, Resetkova A, Lopez A, et al. Sentinel lymph node (SLN) sam-
pling in patients with core biopsy diagnosis of ductal carcinoma
in
situ
(DCIS): UT M.D. Anderson Cancer Center experience and future
recommendations.
Mod Pathol
2006;19(Suppl. 1):30A.
324. Banys M, Gruber I, Krawczyk N, et al. Hematogenous and lymphatic
tumor cell dissemination may be detected in patients diagnosed
271. Charteris AA. On the changes in the mammary gland preceding carci-
noma.
J Pathol
1930;33:101–117.
272. Lagios MD, Westdahl PR, Rose MR. The concept and implications of
multicentricity in breast carcinoma.
Pathol Annu
1981;16:1123–1130.
273. Hardman PDJ, Worth A, Lee U. The risk of occult invasive breast can-
cer after excisional biopsy showing in-situ ductal carcinoma of com-
edo pattern.
Can J Surg
1989;32:56–60.
274. Ashikari R, Huvos AG, Snyder RE. Prospective study of non-infiltrat-
ing carcinoma of the breast.
Cancer
1977;39:435–439.
275. Gallager HS, Martin JE. Early phases in the development of breast can-
cer.
Cancer
1969;24:1170–1178.
276. Morgenstern L, Kaufman PA, Friedman ND. The case against tylec-
tomy for carcinoma of the breast. The factor of multicentricity.
Am J
Surg
1975;130:251–258.
277. Silverstein MJ, Rosser RJ, Gierson ED, et al. Axillary lymph node
dissection for intraductal carcinoma: is it indicated?
Cancer
1987;59:1819–1824.
278. Schwartz GF, Patchefsky AS, Feig SA, et al. Multicentricity of non-
palpable breast cancer.
Cancer
1980;45:2913–2916.
279. Hollingsworth AB, Stough RG. Multicentric and contralateral invasive
tumors identified with pre-op MRI in patients newly diagnosed with
ductal carcinoma
in situ
of the breast.
Breast J
2012;18:420–427.
280. Houssami N, Ciatto S, Macaskill P, et al. Accuracy and surgical impact
of magnetic resonance imaging in breast cancer staging: systematic
review and meta-analysis in detection of multifocal and multicentric
cancer.
J Clin Oncol
2008;26:3248–3258.
281. Yerushalmi R, Tyldesley S, Woods R, et al. Is breast-conserving ther-
apy a safe option for patients with tumor multicentricity and multifo-
cality?
Ann Oncol
2012;23:876–881.
282. Ozzello J, Sentipak P. Epithelial-stromal junction of intraductal carci-
noma of the breast.
Cancer
1970;26:1186–1198.
283. Ozzello L. Ultrastructure of intra-epithelial carcinomas of the breast.
Cancer
1971;28:1508–1515.
284. Rajan PB, Perry RH. A quantitative study of patterns of basement
membrane in ductal carcinoma
in situ
(DCIS) of the breast.
Breast J
1995;1:315–321.
285. Tamimi SO, Ahmed A. Stromal changes in early invasive and
non-invasive breast carcinoma: an ultrastructural study.
J Pathol
1986;150:43–49.
286. Barsky SH, Togo S, Garbisa S, et al. Type IV collagenase immunoreac-
tivity in invasive breast carcinoma.
Lancet
1983;1:296–297.
287. Nakano S, Iyama K, Ogawa M, et al. Differential tissular expression
and localization of type IV collagen alpha-1(IV), alpha-5(IV), and
alpha-6(IV) chains and their mRNA in normal breast and in benign
and malignant breast tumors.
Lab Invest
1999;79:281–292.
288. Hewitt RE, Powe DG, Morrell K, et al. Laminin and collagen IV sub-
unit distribution in normal and neoplastic tissues of colorectum and
breast.
Br J Cancer
1997;75:221–229.
289. Frazier TG, Copeland EM, Gallager HS, et al. Prognosis and treatment
in minimal breast cancer.
Am J Surg
1977;133:697–701.
290. Gallager HS, Martin JE. An orientation to the concept of minimal
breast cancer.
Cancer
1971;28:1505–1507.
291. Hutter RVP. The pathologist’s role in minimal breast cancer.
Cancer
1971;28:1527–1536.
292. Ozzello L. The behaviour of basement membranes in intraductal car-
cinoma of the breast.
Am J Pathol
1959;35:887–799.
293. Dewar R, Fadare O, Gilmore H, et al. Best practices in diagnostic im-
munohistochemistry: myoepithelial markers in breast pathology.
Arch
Pathol Lab Med
2011;135:422–429.
294. Pusztaszeri M.
Phenotypic alterations in myoepithelial cells of the
breast in
normal and pathologic conditions
.
Am J Surg Pathol
2010;34:1886.
295. Coyne J, Haboubi NY. Micro-invasive breast carcinoma with granulo-
matous stromal response.
Histopathology
1992;20:184–185.
296. Prasad ML, Hyjek E, Giri DD, et al. Double immunolabeling with cy-
tokeratin and smooth-muscle actin in confirming early invasive carci-
noma of breast.
Am J Surg Pathol
1999;23:176–181.
297. Hou L, Sneige N, Hunt KK, et al. Predictors of invasion in patients
with core-needle biopsy-diagnosed ductal carcinoma
in situ
and rec-
ommendations for a selective approach to sentinel lymph node biopsy
in ductal carcinoma
in situ. Cancer
2006;107:1760–1768.
298. King TA, Farr GH Jr, Cederbom GI, et al. A mass on breast imaging
predicts coexisting invasive carcinoma in patients with a core biopsy
diagnosis of ductal carcinoma
in situ
.
Am Surg
2001;67:907–912.
